Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

NEWS FEEDS

Availability of New Drugs and Americans' Ability to Work

This work examined the extent to which the introduction of new drugs has increased society's ability to produce goods and services by increasing the number of hours worked per member of the working-age population. Under very conservative assumptions, the estimates indicated that the value of the increase in ability to work attributable to new drugs is 2.5 times as great as expenditure on new drugs.

The study also found that the potential of medicines to increase employee productivity should be considered in the design of drug-reimbursement policies. Conversely, policies that broadly reduce the development and utilization of new drugs may ultimately reduce our ability to produce other goods and services.

Due to copyright issues, this study is only available through the JOEM website.

Blog Post

#TBT: Health Care Quality Has Long Been an Important Issue

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Newsletter Volume

E.V.I.dently October 2014

Message From NPCMind the Gap: Improving Quality Measurement in Accountable Care SystemsOur society is obsessed with quality, from the cars that we...
YouTube Videos

Why are quality measures important? We asked health care thought leaders to tell us why.

Quality measurement, tied to financial incentives, is one of many approaches accountable care programs are using to promote system-wide improvement....
Press Release

National Pharmaceutical Council, Discern Health Examine Accountable Care Measures for Specialty Care and Innovative Treatment

Washington, DC (October 28, 2014)— Measuring the quality and cost of health care is an integral part of accountable care, but new research from the...
Press Release

National Pharmaceutical Council, Discern Health Examine Accountable Care Measures for Specialty Care and Innovative Treatment

Washington, DC (October 28, 2014)— Measuring the quality and cost of health care is an integral part of accountable care, but new research from the...
Press Release

NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer

WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...
Press Release

Leading Researchers Outline Principles for Conduct of Comparative Effectiveness Research

WASHINGTON, DC (September 11, 2012)—A new set of principles developed by a group of leading researchers could help to ensure more consistency in how...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Commentary and Testimony Page

Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making

The number of voices in the comparative effectiveness research (CER) conversation is continuing to grow, but not all stakeholders have the same...
Commentary and Testimony Page

Comparative Effectiveness Research and the Changing Health Care Landscape

This content appeared in the January 2, 2012 print edition of Chain Drug Review. In the span of just one year, the health care landscape has...
Commentary and Testimony Page

CER: Who Can Say What, and When Can They Say It?

With billions of dollars in comparative effectiveness research (CER) set for completion in coming years, there will be broader discussions about the...
Commentary and Testimony Page

CER Done Right: Why It Matters

The health care reform law is aimed at reshaping the health care landscape through the creation of many new regulations and regulatory...
YouTube Videos

Why are quality measures important? We asked health care thought leaders to tell us why.

Quality measurement, tied to financial incentives, is one of many approaches accountable care programs are using to promote system-wide improvement....
YouTube Videos

Rapid-Learning Health Care Systems, Explained

Dr. Lucy Savitz, director of research and education, Institute for Healthcare Delivery Research, Intermountain Healthcare, explains rapid learning...
Blog Post

#TBT: Health Care Quality Has Long Been an Important Issue

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

#TBT: Then & Now: Exhibitor Appreciation Week

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

Engaging Consumers in Today's Changing Health Care Payment and Delivery Environment

Earlier this week, National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, spoke at the Bundled Payments Summit in...
Blog Post

The New Pharmaceutical Paradigm: Capturing Value, Improving Access, and Maximizing Outcomes

Dr. Chuck Shih, NPC’s fellow in comparative effectiveness research, discusses how the use and management of pharmaceuticals are being integrated into...

Research

Accountable Care Measures for High-Cost Specialty Care and Innovative Treatment

This research sheds light on gaps in quality measurement and missed opportunities to promote...

Consumer-Directed Health Plans: Pharmacy Benefits & "Better Practices"

On behalf of the National Pharmaceutical Council, Th

2013 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

2013 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

NPC's 2013 survey shows that health care stakeholders have growing expectations for the use of...
  •  
  • 1 of 39
  • >

Commentary & Testimony